Brief: Autolus Announces Pricing Of Public Offering
09/12/2022 02:13
Dec 8 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS ANNOUNCES PRICING OF PUBLIC OFFERING
* AUTOLUS - PRICING OF ITS 75,000,000 AMERICAN DEPOSITARY
SHARES
REPRESENTING 75,000,000 ORDINARY SHARES AT A PRICE OF $2.00/ADS
Source text for Eikon: ID:nGNX2DxHsd
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants